{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:43:27Z","timestamp":1790477007173,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"State major science and technology special projects"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2015ZX09501004-002-002"],"award-info":[{"award-number":["2015ZX09501004-002-002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.taap.2018.06.014","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T04:55:47Z","timestamp":1529038547000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system"],"prefix":"10.1016","volume":"355","author":[{"given":"Zhenlin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-2626","authenticated-orcid":false,"given":"Lili","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.06.014_bb0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.2012.110","article-title":"Nrf2, a potential target for new therapeutics in liver disease","volume":"92","author":"Bataille","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.06.014_bb0010","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.taap.2018.06.014_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0079-6603(08)60843-0","article-title":"Superoxide dismutases","volume":"40","author":"Beyer","year":"1991","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.taap.2018.06.014_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0609.2000.9r200.x","article-title":"Veno-occlusive disease of the liver after hemopoietic cell transplantation","volume":"64","author":"Carreras","year":"2000","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.taap.2018.06.014_bb0025","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1016\/j.febslet.2006.11.007","article-title":"Mitochondrial thioredoxin in regulation of oxidant-induced cell death","volume":"580","author":"Chen","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2018.06.014_bb0030","series-title":"Pharmacopeia of the people's Republic of China (2015) Version","first-page":"86","author":"Chinese Pharmacopoeia Commission","year":"2015"},{"key":"10.1016\/j.taap.2018.06.014_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2018.06.014_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.taap.2018.06.014_bb0045","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3748\/wjg.v13.i10.1628","article-title":"Gynura root induces hepatic veno-occlusive disease a case report and review of the literature","volume":"13","author":"Dai","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2018.06.014_bb0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic Veno-occlusive disease after hematopoietic stem cell transplantation risk factors and stratification, prophylaxis, and treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.taap.2018.06.014_bb0055","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"Deleve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2018.06.014_bb0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2018.06.014_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of oxidative damage in human disease","volume":"52","author":"Donne","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2018.06.014_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/ars.2007.1716","article-title":"Molecular mechanisms and potential clinical significance of S-glutathionylation","volume":"10","author":"Donne","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2018.06.014_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2018.06.014_bb0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)","volume":"4","author":"Fan","year":"2014","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.taap.2018.06.014_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MCB.25.1.162-171.2005","article-title":"BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase","volume":"25","author":"Furukawa","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2018.06.014_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jep.2014.12.043","article-title":"A protective mechanism of licorice (Glycyrrhiza uralensis) isoliquritigenin stimulates detoxification system via Nrf2 activation","volume":"162","author":"Gong","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2018.06.014_bb0095","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0891-5849(99)00176-8","article-title":"Biologic and pharmacologic regulation of mammalian glutathione synthesis","volume":"27","author":"Griffith","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2018.06.014_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10715769900300851","article-title":"Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress","volume":"31","author":"Hayes","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.taap.2018.06.014_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.06.014_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2018.06.014_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the aminoterminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.taap.2018.06.014_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.03.035","article-title":"The involvement of p62-Keap1-Nrf2 antioxidant signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity","volume":"85","author":"Ji","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2018.06.014_bb0125","first-page":"C849","article-title":"Radical-free biology of oxidative stress","volume":"295","author":"Jones","year":"2008","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.taap.2018.06.014_bb0130","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.bjc.6603097","article-title":"High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy","volume":"94","author":"de Jonge","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2018.06.014_bb0135","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2018.06.014_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2006.03.008","article-title":"Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine","volume":"161","author":"Kim","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2018.06.014_bb0145","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2018.06.014_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.taap.2018.06.014_bb0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bmc.2017.11.046","article-title":"Antitussive and expectorant activities of licorice and its major compounds","volume":"26","author":"Kuang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.taap.2018.06.014_bb0160","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/ars.2011.4322","article-title":"Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance","volume":"18","author":"Lee","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2018.06.014_bb0165","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/jcp.29.9.788","article-title":"A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption","volume":"29","author":"Mcgee","year":"1976","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.taap.2018.06.014_bb0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.suronc.2016.05.030","article-title":"The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: a systematic review with meta-analysis","volume":"25","author":"van Mierlo","year":"2016","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.taap.2018.06.014_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(76)90726-1","article-title":"An outbreak of hepatic veno-occlusive disease in North-Western Afghanistan","volume":"2","author":"Mohabbat","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2018.06.014_bb0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jceh.2017.09.004","article-title":"Matrix metalloproteinases (MMPs) in liver diseases","volume":"7","author":"Naim","year":"2017","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.taap.2018.06.014_bb0185","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2012.07.004","article-title":"Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9","volume":"57","author":"Nakamura","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2018.06.014_bb0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jss.2014.08.052","article-title":"Regorafenib suppresses sinusoidal obstruction syndrome in rats","volume":"193","author":"Okuno","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.taap.2018.06.014_bb0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1248\/bpb.b14-00430","article-title":"Tacrine, an oral acetylcholinesterase inhibitor, induced hepatic oxidative damage, which was blocked by liquiritigenin through GSK3-beta inhibition","volume":"38","author":"Park","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2018.06.014_bb0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12013-011-9215-3","article-title":"Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9","volume":"61","author":"Periasamy","year":"2011","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.taap.2018.06.014_bb0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2018.06.014_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3350\/cmh.2014.20.1.81","article-title":"Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy","volume":"20","author":"Seo","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.taap.2018.06.014_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2018.06.014_bb0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1432-1327.1999.00286.x","article-title":"Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization","volume":"261","author":"Vizuete","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.taap.2018.06.014_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1751-2980.12112","article-title":"Tusanqi and hepatic sinusoidal syndrome","volume":"15","author":"Wang","year":"2014","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.taap.2018.06.014_bb0230","article-title":"Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.taap.2018.06.014_bb0235","article-title":"Natural polyphenol chlorogenic acid protects against acetaminophen-induced hepatotoxicity by activating ERK\/Nrf2 antioxidative pathway","author":"Wei","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.06.014_bb0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.taap.2009.08.018","article-title":"A systems biology perspective on Nrf2-mediated antioxidant response","volume":"244","author":"Zhang","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.06.014_bb0245","doi-asserted-by":"crossref","first-page":"649568","DOI":"10.1155\/2015\/649568","article-title":"Liquiritigenin protects rats from carbon tetrachloride induced hepatic injury through PGC-1alpha pathway","volume":"2015","author":"Zhang","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:47:43Z","timestamp":1758574063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18302722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":49,"alternative-id":["S0041008X18302722"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.06.014","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}